EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Autologous T cells targeting Epstein-Barr virus (EBV) latent membrane proteins (LMPs) have shown safety and efficacy in the treatment of patients with type 2 latency EBV-associated lymphomas for whom standard therapies have failed, including high-dose chemotherapy followed by autologous stem-cell re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: McLaughlin, Lauren P., Rouce, Rayne, Gottschalk, Stephen, Torrano, Vicky, Carrum, George, Wu, Meng-Fen, Hoq, Fahmida, Grilley, Bambi, Marcogliese, Andrea M., Hanley, Patrick J., Gee, Adrian P., Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E., Bollard, Catherine M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6265652/
https://ncbi.nlm.nih.gov/pubmed/30262660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-07-863654
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados